2009
Association of the 1082 G/A promoter polymorphism of interleukin - 10 gene with the antibodies production in patients with rheumatoid arthritis
NĚMEC, Petr; Monika PAVKOVA-GOLDBERGOVA; Jindra GATTEROVA; Zdeněk FOJTÍK; Anna VAŠKŮ et al.Základní údaje
Originální název
Association of the 1082 G/A promoter polymorphism of interleukin - 10 gene with the antibodies production in patients with rheumatoid arthritis
Název česky
Vztah polymorfismu 1082 G/A promotor genu interleunin-10 a produkce protilátek u pacientů s revmatoidní artritidou
Autoři
NĚMEC, Petr; Monika PAVKOVA-GOLDBERGOVA; Jindra GATTEROVA; Zdeněk FOJTÍK; Anna VAŠKŮ a Miroslav SOUČEK
Vydání
Clin Rheumatol, London, Springer, 2009, 0770-3198
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.668
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/09:00039347
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
rheumatoid arthritis; Interleukin-10; autoantibodies;
Změněno: 21. 3. 2010 15:01, doc. MUDr. Helena Němcová, CSc.
Anotace
V originále
Interleukin-10 (IL-10) is an immunoregulatory cytokine, usually considered to mediate the downregulation of the inflammatory response in rheumatoid arthritis (RA). Some effects of IL-10 are not anti-inflammatory; for example, the activation of B cells to promote autoantibody production. Allelic polymorphisms located in the promoter region of the IL-10 gene may contribute to the regulation of autoantibodies production. To examine the putative association between the -1082 G/A polymorphism in the promoter region of the IL-10 gene and the susceptibility to disease onset and severity of RA, a total of 144 patients with RA diagnosed according to the revised criteria of the American College of Rheumatology for RA were consecutively recruited into the study. Radiographic progression of RA was scored according to the Sharp/van der Heijde method. Serum levels of rheumatoid factors (RFs) were measured by enzyme-linked immunosorbent assay. Polymerase chain reaction amplification was used for the analysis of the promoter polymorphism of the IL-10 gene. We observed significant differences in genotype distribution of the -1082 G/A polymorphism between IgM RF, IgA RF, and IgG RF positive/negative subgroups of RA patients, with higher prevalence of the GG genotype within IgM RF (Pg = 0.006), IgA RF (Pg = 0.05), and IgG RF (Pg = 0.007) negative RA patients. Results obtained in this study provide the evidence of an association between the -1082 G/A polymorphism in the IL-10 gene promoter and the production of RFs in RA patients.